Maternal Marijuana Use and Fetal and Infant Outcome

  • STATUS
    Recruiting
  • participants needed
    20
  • sponsor
    Johns Hopkins University
Send
Updated on 16 February 2024
See if I qualify
addiction
marijuana use
fetal monitoring
illicit substance use

Summary

Marijuana and cannabis-containing products are growing in popularity and availability in the United States, and use during pregnancy has increased dramatically. The overarching aim of this proposal is to provide pilot data for a submission which will explore the impact of chronic maternal marijuana use (primary or secondary) on fetal functioning, maternal reflective functioning and infant birth and neurodevelopmental outcomes. Chronically marijuana using pregnant women in treatment at the Center for Addiction and Pregnancy will be enrolled and asked to provide information about participants' marijuana and other licit and illicit substance use and feelings about parenting and participants' infant and undergo fetal monitoring at 36 weeks gestation. The neonates will undergo neurobehavioral examination during the first and fourth weeks of life.

Details
Condition Pregnancy Related, Cannabis Use Disorder
Age 18years - 44years
Treatment Maternal-fetal monitoring, NICU Network Neurobehavioral Scale
Clinical Study IdentifierNCT04266314
SponsorJohns Hopkins University
Last Modified on16 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Singleton pregnancy less than 36 weeks of gestation
Marijuana as a primary or secondary drug of choice

Exclusion Criteria

Significant fetal anomaly
Multiple gestation
Delivery prior to 36 weeks gestation
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

addiction
marijuana use
fetal monitoring
illicit substance use

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.